Ischaemic heart disease - coronary artery stents (TA71)
Fast, easy summary view of NICE guidance on 'acute coronary syndromes'
Fast, easy summary view of NICE guidance on 'stable angina'
Sections 1.2-1.4 of this guidance have been replaced by TA152 Coronary artery disease - drug-eluting stents
NICE has made the following recommendations about the use of stents in operations for coronary artery disease.
A stent should normally be used during balloon angioplasty in a person who has angina or has had a heart attack.
The decision on which type of stent to use should depend on the person?s symptoms, and on the size and shape of the narrowed part of the artery. A drug-eluting stent should be used if the person has angina, and the inside diameter of the artery is less than 3 mm across, or the narrowed area is more than 15 mm long. There are several different drug-eluting stents, which contain different drugs. NICE recommends stents that contain either a drug called sirolimus, or one called paclitaxel, because most of the research has been on these.
If more than one artery is narrowed, doctors should make the decision on which type of stent to use for each artery separately.
This guidance covers treatment for people who would normally be offered some form of balloon angioplasty. NICE has not made any recommendations on using stents to treat people who have had a heart attack in the previous 24 hours, or people who had a clot in the narrowed artery.
This guidance updates and replaces NICE technology appraisal 4 (published in May 2000)
- TA71 Ischaemic heart disease - coronary artery stents: guidance (web format)
- TA71 Ischaemic heart disease - coronary artery stents: summary
- TA71 Ischaemic heart disease - coronary artery stents: common questions and answers
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
- Assessment report: Coronary artery stents rapid systematic review and economic evaluation
- Assessment report: Coronary artery stents rapid systematic review and economic evaluation - addendum A
- Assessment report: Coronary artery stents rapid systematic review and economic evaluation - addendum B
- NICE issues updated guidance on the use of coronary artery stents for the treatment of coronary artery disease
This page was last updated: 13 February 2014
Information for the public
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.